Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
This article was originally published in The Tan Sheet
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary
You may also be interested in...
FDA's Division of Nonprescription Regulation Development will hire additional staff to accelerate monograph work and enhance the office's internal expertise
The White House's appointment of two former health commissioners to run FDA sends a strong message that the agency will refocus on public health, particularly food safety
The White House is set to nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner, according to sources knowledgeable about the selection process